In this study, we have demonstrated that copper chelation can inhibit epithelial-mesenchymal transition and shift cell properties from a mesenchymal state to a more epithelial-like phenotype in TNBC, NB and DIPG cancer cells via attenuating TGF-β signaling pathway activation and impair tumor invasiveness. This evidence concerns the gene TGFB1 and neuroblastoma.